PL2515855T6 - Terapia skojarzona dla POChP - Google Patents

Terapia skojarzona dla POChP

Info

Publication number: PL2515855T6
Authority: PL; Poland
Prior art keywords: copd; combination therapy; therapy; combination
Prior art date: 2009-12-23

Application number

PL10799030.1T

Other languages

English (en)

Other versions

PL2515855T3 (pl

Inventor

Sauro Bonelli

Francesca Usberti

Enrico Zambelli

Original Assignee

Chiesi Farmaceutici S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-12-23

Filing date

2010-12-22

Publication date

2023-12-18

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42107420&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2515855(T6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-12-22 Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.

2014-08-29 Publication of PL2515855T3 publication Critical patent/PL2515855T3/pl

2023-12-18 Publication of PL2515855T6 publication Critical patent/PL2515855T6/pl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/003—Adding propellants in fluid form to aerosol containers
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B7/00—Closing containers or receptacles after filling
- B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
- B65B7/28—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
- B65B7/2842—Securing closures on containers
- B65B7/285—Securing closures on containers by deformation of the closure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Dispersion Chemistry (AREA)
Mechanical Engineering (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Heart & Thoracic Surgery (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
External Artificial Organs (AREA)

PL10799030.1T 2009-12-23 2010-12-22 Terapia skojarzona dla POChP PL2515855T6 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP09180671		2009-12-23
PCT/EP2010/070479 WO2011076843A2 (en)	2009-12-23	2010-12-22	Combination therapy for copd
EP10799030.1A EP2515855B3 (en)	2009-12-23	2010-12-22	Combination therapy for COPD

Publications (2)

Publication Number	Publication Date
PL2515855T3 PL2515855T3 (pl)	2014-08-29
PL2515855T6 true PL2515855T6 (pl)	2023-12-18

Family

ID=42107420

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10799030.1T PL2515855T6 (pl)	2009-12-23	2010-12-22	Terapia skojarzona dla POChP

Country Status (40)

Country	Link
US (3)	US20110150782A1 (pl)
EP (1)	EP2515855B3 (pl)
JP (2)	JP5914354B2 (pl)
KR (2)	KR20170040392A (pl)
CN (2)	CN104055765B (pl)
AR (2)	AR079726A1 (pl)
AU (3)	AU2010334859A1 (pl)
BR (1)	BR112012015337B8 (pl)
CA (1)	CA2785321C (pl)
CL (1)	CL2012001705A1 (pl)
CO (1)	CO6541628A2 (pl)
CY (2)	CY1115116T1 (pl)
DK (1)	DK2515855T6 (pl)
EA (2)	EA021917B1 (pl)
ES (1)	ES2468840T7 (pl)
FI (2)	FIC20170064I1 (pl)
GE (1)	GEP20156311B (pl)
HK (2)	HK1174566A1 (pl)
HR (1)	HRP20140582T4 (pl)
HU (1)	HUS1800001I1 (pl)
IL (1)	IL260932B (pl)
LT (1)	LTC2515855I2 (pl)
LU (1)	LUC00060I2 (pl)
MA (1)	MA33823B1 (pl)
MX (1)	MX2012006878A (pl)
MY (1)	MY156949A (pl)
NL (1)	NL300923I2 (pl)
NO (1)	NO2018001I2 (pl)
NZ (1)	NZ600790A (pl)
PE (2)	PE20160853A1 (pl)
PL (1)	PL2515855T6 (pl)
PT (1)	PT2515855E (pl)
RS (1)	RS53391B2 (pl)
SG (1)	SG181868A1 (pl)
SI (1)	SI2515855T1 (pl)
TN (1)	TN2012000269A1 (pl)
TW (1)	TWI495468B (pl)
UA (1)	UA113832C2 (pl)
WO (1)	WO2011076843A2 (pl)
ZA (1)	ZA201204615B (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2011076842A2 (en) *	2009-12-23	2011-06-30	Chiesi Farmaceutici S.P.A.	Aerosol formulation for copd
CA2785349C (en) *	2009-12-23	2018-07-03	Chiesi Farmaceutici S.P.A.	Combination therapy for copd
UA113832C2 (xx) *	2009-12-23	2017-03-27		Комбінаційна терапія для хозл
EP2749283A3 (en) *	2011-02-17	2014-08-20	Cipla Limited	Combination of glycopyrronium and olodaterol
CN103874483B (zh) *	2011-10-11	2017-09-12	奇斯药制品公司	包衣了脂肪酸的β‑激动剂的晶体微粒
CN104918604A (zh) *	2012-10-23	2015-09-16	西普拉有限公司	药物组合物
ES2699986T3 (es) *	2013-07-11	2019-02-13	Chiesi Farm Spa	Formulación de polvo seco que comprende un anticolinérgico, un corticosteroide y un betaadrenérgico para administración por inhalación
MA39154A1 (fr) *	2013-12-30	2017-08-31	Chiesi Farm Spa	Composition stable pressurisée de solution pour aérosol d'une combinaison de bromure de glycopyrronium et de formotérol
CA2935305C (en) *	2013-12-30	2022-07-12	Chiesi Farmaceutici S.P.A.	Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
US11039620B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9622483B2 (en)	2014-02-19	2017-04-18	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US11039621B2 (en)	2014-02-19	2021-06-22	Corning Incorporated	Antimicrobial glass compositions, glasses and polymeric articles incorporating the same
US9554992B2 (en) *	2014-06-09	2017-01-31	Chiesi Farmaceutici S.P.A.	Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
GB201416909D0 (en) *	2014-09-25	2014-11-12	Prosonix Ltd	Method of forming concentrated solution
US20160310410A1 (en)	2015-04-24	2016-10-27	Glenmark Specialty S.A.	Pharmaceutical compositions comprising arformoterol and glycopyrronium
ME03778B (me)	2015-11-16	2021-04-20	Chiesi Farm Spa	Postupak za pripremu formulacije suvog praha obuhvatajući antiholinergik, kortikosteroid i beta -adrenergik
GB2545025A (en) *	2015-12-04	2017-06-07	Mexichem Fluor Sa De Cv	Pharmaceutical composition
EP3436115B1 (en)	2016-03-31	2021-07-28	Chiesi Farmaceutici S.p.A.	Aerosol inhalation device
US10098837B2 (en) *	2016-07-28	2018-10-16	Chiesi Farmaceutici S.P.A.	Combination therapy for COPD
ES2956521T3 (es) *	2016-09-19	2023-12-22	Mexichem Fluor Sa De Cv	Composición farmacéutica que comprende bromuro de tiotropio
EP3515425B1 (en)	2016-09-19	2021-06-09	Mexichem Fluor S.A. de C.V.	Pharmaceutical composition comprising salmeterol
MY202069A (en)	2016-09-19	2024-03-31	Mexichem Fluor Sa De Cv	Pharmaceutical composition
WO2018206619A1 (en) *	2017-05-11	2018-11-15	Chiesi Farmaceutici S.P.A.	A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
CA3060020A1 (en)	2017-05-11	2018-11-15	Chiesi Farmaceutici S.P.A.	A process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
CA3152578A1 (en) *	2019-12-02	2021-06-10	Enrico Zambelli	Stainles steel can for pressurised metered dose inhalers
EP4188327A1 (en)	2020-07-31	2023-06-07	Chemo Research, S.L.	Combination therapy for inhalation administration
WO2022074183A1 (en)	2020-10-09	2022-04-14	Chiesi Farmaceutici S.P.A.	A pharmaceutical formulation for pressurised metered dose inhaler
WO2023227781A1 (en)	2022-05-27	2023-11-30	Chiesi Farmaceutici S.P.A.	A pharmaceutical formulation for pressurised metered dose inhaler
WO2023227782A1 (en)	2022-05-27	2023-11-30	Chiesi Farmaceutici S.P.A.	A pharmaceutical formulation for pressurised metered dose inhaler
WO2023227783A1 (en)	2022-05-27	2023-11-30	Chiesi Farmaceutici S.P.A.	A pharmaceutical formulation for pressurised metered dose inhaler

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2956062A (en)	1959-02-26	1960-10-11	Robins Co Inc A H	Esters of amino alcohols
PL177078B1 (pl)	1992-12-09	1999-09-30	Boehringer Ingelheim Pharma	Preparaty roztworów aerozolowych
WO2000006121A1 (de)	1998-07-24	2000-02-10	Jago Research Ag	Medizinische aerosolformulierungen
PT1102579E (pt) *	1998-08-04	2003-07-31	Jago Res Ag	Formulacoes de aerossol medicinais
US20060171899A1 (en) *	1998-12-10	2006-08-03	Akwete Adjei	Water-stabilized aerosol formulation system and method of making
IT1317720B1 (it)	2000-01-07	2003-07-15	Chiesi Farma Spa	Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
GB0008660D0 (en)	2000-04-07	2000-05-31	Arakis Ltd	The treatment of respiratory diseases
MXPA02011414A (es)	2000-05-22	2003-06-06	Chiesi Farma Spa	Formulaciones farmaceuticas en solucion estable para inhaladores presurizados con medicion de dosis.
US20060257324A1 (en) *	2000-05-22	2006-11-16	Chiesi Farmaceutici S.P.A.	Pharmaceutical solution formulations for pressurised metered dose inhalers
US20040101483A1 (en)	2001-03-30	2004-05-27	Rudi Muller-Walz	Medical aerosol formulations
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
EP1321159A1 (en)	2001-12-21	2003-06-25	CHIESI FARMACEUTICI S.p.A.	Pressurized metered dose inhaler (pMDI) actuators with laser drilled orifices
EP3536344B1 (en)	2002-03-01	2020-02-19	Chiesi Farmaceutici S.p.A.	Formoterol superfine formulation
RU2005122444A (ru)	2002-12-16	2007-01-27	Берингер Ингельхайм Фарма Гмбх Унд Ко.Кг (De)	Композиции в виде содержащих тиотропий растворов с гидрофторуглеродом
AR041873A1 (es) *	2003-10-30	2005-06-01	Pablo Cassara Srl Lab	Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
PT1718336E (pt) *	2004-02-06	2008-08-28	Meda Pharma Gmbh & Co Kg	Nova combinação de anticolinérgico e beta miméticos para o tratamento de doenças respiratórias
WO2005074918A1 (en)	2004-02-06	2005-08-18	Benzstrasse 1 D-61352 Bad Homburd	The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd
GB0410399D0 (en)	2004-05-10	2004-06-16	Arakis Ltd	The treatment of respiratory disease
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
EP1616567A1 (en)	2004-07-16	2006-01-18	Boehringer Ingelheim Pharma GmbH & Co.KG	Medicaments for inhalation comprising PDE IV inhibitors and glycopyrrolate salts
GB0505545D0 (en)	2005-03-17	2005-04-27	Glaxo Group Ltd	Inhalation devices
MX2007012084A (es)	2005-03-30	2007-11-21	Schering Corp	Medicamentos y metodos que combinan un anticolinergico, un corticosteroide y un agonista beta de accion prolongada.
GB0523653D0 (en)	2005-11-21	2005-12-28	Novartis Ag	Organic compounds
US8235044B2 (en)	2005-08-01	2012-08-07	Astrazeneca Ab	Inhaler valve
GB0523655D0 (en)	2005-11-21	2005-12-28	Novartis Ag	Organic compounds
GB0523654D0 (en)	2005-11-21	2005-12-28	Novartis Ag	Organic compounds
GB0523656D0 (en)	2005-11-21	2005-12-28	Novartis Ag	Organic compounds
CA2824075C (en) *	2005-12-21	2015-04-28	Joachim Maus	Combination of r, r-glycopyrrolate, formoterol, and a glucocorticoid for the treatment of inflammatory diseases
GB0613161D0 (en) *	2006-06-30	2006-08-09	Novartis Ag	Organic Compounds
EP1894568A1 (en)	2006-08-31	2008-03-05	Novartis AG	Pharmaceutical compositions for the treatment of inflammatory or obstructive airway diseases
AU2008314628B2 (en)	2007-10-18	2014-03-06	Rose U	Topical glycopyrrolate formulations
AU2010258751A1 (en) *	2009-06-09	2012-02-02	Sunovion Respiratory Development Inc.	Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration
CA2785349C (en) *	2009-12-23	2018-07-03	Chiesi Farmaceutici S.P.A.	Combination therapy for copd
UA113832C2 (xx) *	2009-12-23	2017-03-27		Комбінаційна терапія для хозл
WO2011076842A2 (en) *	2009-12-23	2011-06-30	Chiesi Farmaceutici S.P.A.	Aerosol formulation for copd
CA2785347C (en)	2009-12-23	2018-02-27	Chiesi Farmaceutici S.P.A.	Aerosol formulation for copd
ES2699986T3 (es) *	2013-07-11	2019-02-13	Chiesi Farm Spa	Formulación de polvo seco que comprende un anticolinérgico, un corticosteroide y un betaadrenérgico para administración por inhalación
MA39154A1 (fr)	2013-12-30	2017-08-31	Chiesi Farm Spa	Composition stable pressurisée de solution pour aérosol d'une combinaison de bromure de glycopyrronium et de formotérol
CA2935305C (en) *	2013-12-30	2022-07-12	Chiesi Farmaceutici S.P.A.	Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination
US9554992B2 (en) *	2014-06-09	2017-01-31	Chiesi Farmaceutici S.P.A.	Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic
US10098837B2 (en) *	2016-07-28	2018-10-16	Chiesi Farmaceutici S.P.A.	Combination therapy for COPD

2010
- 2010-12-22 UA UAA201207626A patent/UA113832C2/uk unknown
- 2010-12-22 GE GEAP201012756A patent/GEP20156311B/en unknown
- 2010-12-22 DK DK10799030.1T patent/DK2515855T6/da active
- 2010-12-22 MX MX2012006878A patent/MX2012006878A/es active IP Right Grant
- 2010-12-22 MY MYPI2012002844A patent/MY156949A/en unknown
- 2010-12-22 EA EA201290375A patent/EA021917B1/ru active Protection Beyond IP Right Term
- 2010-12-22 NZ NZ600790A patent/NZ600790A/en unknown
- 2010-12-22 CN CN201410289445.6A patent/CN104055765B/zh active Active
- 2010-12-22 CA CA2785321A patent/CA2785321C/en active Active
- 2010-12-22 JP JP2012545323A patent/JP5914354B2/ja active Active
- 2010-12-22 EA EA201590179A patent/EA027778B1/ru active Protection Beyond IP Right Term
- 2010-12-22 WO PCT/EP2010/070479 patent/WO2011076843A2/en active Application Filing
- 2010-12-22 KR KR1020177009412A patent/KR20170040392A/ko active Search and Examination
- 2010-12-22 PE PE2016000787A patent/PE20160853A1/es unknown
- 2010-12-22 PT PT107990301T patent/PT2515855E/pt unknown
- 2010-12-22 TW TW099145166A patent/TWI495468B/zh active
- 2010-12-22 EP EP10799030.1A patent/EP2515855B3/en active Active
- 2010-12-22 PE PE2012000865A patent/PE20121396A1/es not_active Application Discontinuation
- 2010-12-22 RS RS20140338A patent/RS53391B2/sr unknown
- 2010-12-22 AR ARP100104922A patent/AR079726A1/es not_active Application Discontinuation
- 2010-12-22 SG SG2012046157A patent/SG181868A1/en unknown
- 2010-12-22 AU AU2010334859A patent/AU2010334859A1/en not_active Abandoned
- 2010-12-22 SI SI201030654T patent/SI2515855T1/sl unknown
- 2010-12-22 PL PL10799030.1T patent/PL2515855T6/pl unknown
- 2010-12-22 CN CN201080058048.8A patent/CN102665679B/zh active Active
- 2010-12-22 ES ES10799030T patent/ES2468840T7/es active Active
- 2010-12-22 BR BR112012015337A patent/BR112012015337B8/pt active IP Right Grant
- 2010-12-22 KR KR1020127015996A patent/KR101757951B1/ko active IP Right Grant
- 2010-12-23 US US12/977,159 patent/US20110150782A1/en not_active Abandoned
2012
- 2012-05-29 TN TNP2012000269A patent/TN2012000269A1/en unknown
- 2012-06-01 CO CO12092198A patent/CO6541628A2/es unknown
- 2012-06-14 MA MA34966A patent/MA33823B1/fr unknown
- 2012-06-21 CL CL2012001705A patent/CL2012001705A1/es unknown
- 2012-06-21 ZA ZA2012/04615A patent/ZA201204615B/en unknown
2013
- 2013-02-15 HK HK13101936.0A patent/HK1174566A1/xx unknown
2014
- 2014-05-29 CY CY20141100382T patent/CY1115116T1/el unknown
- 2014-06-23 HR HRP20140582TT patent/HRP20140582T4/hr unknown
- 2014-10-23 HK HK14110591A patent/HK1197036A1/xx unknown
2015
- 2015-07-29 US US14/812,190 patent/US10159645B2/en active Active
2016
- 2016-04-04 JP JP2016075136A patent/JP6283388B2/ja active Active
- 2016-09-27 AU AU2016234895A patent/AU2016234895B2/en active Active
2017
- 2017-12-22 CY CY2017047C patent/CY2017047I2/el unknown
- 2017-12-29 FI FIC20170064C patent/FIC20170064I1/fi unknown
- 2017-12-29 FI FIEP10799030.1T patent/FI2515855T6/fi active
2018
- 2018-01-05 HU HUS1800001C patent/HUS1800001I1/hu unknown
- 2018-01-10 NO NO2018001C patent/NO2018001I2/no unknown
- 2018-01-10 LU LU00060C patent/LUC00060I2/fr unknown
- 2018-01-11 LT LTPA2018001C patent/LTC2515855I2/lt unknown
- 2018-01-12 NL NL300923C patent/NL300923I2/en unknown
- 2018-04-30 AU AU2018202998A patent/AU2018202998A1/en not_active Abandoned
- 2018-08-01 IL IL260932A patent/IL260932B/en active IP Right Grant
- 2018-10-16 US US16/161,427 patent/US11389401B2/en active Active
2019
- 2019-08-02 AR ARP190102199A patent/AR115897A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
BR112012015337B1 (pt)	2021-05-04
US20110150782A1 (en)	2011-06-23
CY1115116T1 (el)	2016-12-14
CN104055765A (zh)	2014-09-24
CA2785321C (en)	2018-08-21
CN102665679B (zh)	2014-11-26
EA021917B1 (ru)	2015-09-30
AR115897A2 (es)	2021-03-10
BR112012015337A2 (pt)	2016-03-15
CO6541628A2 (es)	2012-10-16
NO2018001I1 (no)	2018-01-10
HUS1800001I1 (hu)	2018-02-28
MY156949A (en)	2016-04-15
MX2012006878A (es)	2012-07-04
IL260932B (en)	2021-04-29
AU2016234895A1 (en)	2016-10-13
US11389401B2 (en)	2022-07-19
KR101757951B1 (ko)	2017-07-13
HRP20140582T4 (hr)	2023-06-09
AU2010334859A1 (en)	2012-07-12
EP2515855A2 (en)	2012-10-31
KR20170040392A (ko)	2017-04-12
CN104055765B (zh)	2016-11-23
TWI495468B (zh)	2015-08-11
HK1174566A1 (en)	2013-06-14
BR112012015337B8 (pt)	2021-05-25
LUC00060I2 (pl)	2018-03-16
LUC00060I1 (pl)	2018-01-18
AU2016234895B2 (en)	2018-02-01
EP2515855B1 (en)	2014-04-02
NO2018001I2 (no)	2018-01-10
WO2011076843A2 (en)	2011-06-30
PE20121396A1 (es)	2012-10-24
RS53391B2 (sr)	2023-09-29
TW201129359A (en)	2011-09-01
DK2515855T3 (da)	2014-06-30
DK2515855T6 (da)	2023-06-06
FIC20170064I1 (fi)	2017-12-29
JP6283388B2 (ja)	2018-02-21
CL2012001705A1 (es)	2012-09-28
LTC2515855I2 (lt)	2019-05-10
JP5914354B2 (ja)	2016-05-11
EA201590179A1 (ru)	2015-09-30
RS53391B (en)	2014-10-31
US10159645B2 (en)	2018-12-25
HK1197036A1 (en)	2015-01-02
US20150328144A1 (en)	2015-11-19
CA2785321A1 (en)	2011-06-30
CN102665679A (zh)	2012-09-12
NZ600790A (en)	2014-09-26
TN2012000269A1 (en)	2013-12-12
CY2017047I1 (el)	2018-04-04
PE20160853A1 (es)	2016-09-14
WO2011076843A3 (en)	2011-12-01
MA33823B1 (fr)	2012-12-03
EA027778B1 (ru)	2017-08-31
PL2515855T3 (pl)	2014-08-29
NL300923I2 (en)	2019-07-22
FI2515855T6 (fi)	2023-06-02
UA113832C2 (xx)	2017-03-27
CY2017047I2 (el)	2018-04-04
KR20120103653A (ko)	2012-09-19
JP2016145239A (ja)	2016-08-12
ES2468840T3 (es)	2014-06-17
SI2515855T1 (sl)	2014-08-29
LTPA2018001I1 (lt)	2018-02-12
NL300923I1 (en)	2018-01-17
JP2013515696A (ja)	2013-05-09
EA201290375A1 (ru)	2013-01-30
AR079726A1 (es)	2012-02-15
US20190046433A1 (en)	2019-02-14
ES2468840T7 (es)	2023-11-29
HRP20140582T1 (hr)	2014-08-01
AU2018202998A1 (en)	2018-05-17
EP2515855B3 (en)	2023-05-03
ZA201204615B (en)	2013-09-25
SG181868A1 (en)	2012-07-30
GEP20156311B (en)	2015-07-10
PT2515855E (pt)	2014-06-11

Publication	Publication Date	Title
HUS1800001I1 (hu)	2018-02-28	Kombinációs terápia COPD-hez
HK1174571A1 (en)	2013-06-14	Combination therapy for copd copd
AP3250A (en)	2015-05-31	Tablets for combination therapy
IL214919A0 (en)	2011-11-30	Method for therapeutic use
IL215481A0 (en)	2011-12-29	Improved glucocorticoid therapy
EP2510949A4 (en)	2013-11-13	THERAPEUTICS FOR FIBROMYALGIA
EP2427183A4 (en)	2014-01-08	THERAPEUTIC COMPOUNDS
EP2496704A4 (en)	2013-05-01	THERAPEUTIC COMPOUNDS
GB0916997D0 (en)	2009-11-11	Combination therapy
EP2515645A4 (en)	2013-10-23	ANTIMYCOTIC THERAPY
GB201012648D0 (en)	2010-09-15	Securing apparatus
GB0902916D0 (en)	2009-04-08	Antibody therapy
GB0901487D0 (en)	2009-03-11	Asthma Therapy
GB0907973D0 (en)	2009-06-24	Combination therapy
EP2456309A4 (en)	2013-04-03	THERAPEUTIC COMPOUNDS
GB0906026D0 (en)	2009-05-20	Therapeutic compounds
GB0903321D0 (en)	2009-04-08	Therapy
GB0903319D0 (en)	2009-04-08	Therapy
GB0921244D0 (en)	2010-01-20	Therapy
GB0914820D0 (en)	2009-09-30	WATerian therapy
GB0901497D0 (en)	2009-03-11	Compound for therapy
GB0914441D0 (en)	2009-09-30	Compound for therapy
GB0903080D0 (en)	2009-04-08	Compound for therapy
GB2470221B (en)	2014-08-20	Securing apparatus
GB0916608D0 (en)	2009-11-04	Therapeutic compounds